PUBCHEM ID |
121494086
|
UNII |
JD0HM3LMNW
|
Preferred Term |
BLEOMYCIN B2 HYDROCHLORIDE
|
CAS |
55658-44-1
|
INCHIKEY |
ZNLSDKREHVABLV-WEJIAYKGSA-N
|
Download |
mol2, pdbqt
|
mol2 |
|
Smiles |
C[C@H]([C@H]([C@H](C)NC([C@@H]([C@@H](c1cnc[nH]1)O[C@H]([C@@H]([C@@H]1O)O[C@@H]([C@@H]([C@@H]2OC(N)=O)O)O[C@@H](CO)[C@@H]2O)O[C@H](CO)[C@@H]1O)NC(c1nc([C@@H](CC(N)=O)NC[C@H](C(N)=O)N)nc(N)c1C)=O)=O)O)C(N[C@H]([C@H](C)O)C(NCCc1nc(-c2nc(C(NCCCCN=C(N)N)=O)cs
|
Total Surface Area |
1019,1
|
Relative PSA |
0,54542
|
TPSA |
747,95
|
cLogS |
-2,065
|
MW |
1425,52
|
cLogP |
-11,204
|
H-Acceptors |
41
|
H-Donors |
22
|
Ro5 violations |
3
|
Druglikeness |
4,4188
|
DrugScore |
0,484493455534026
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA-
|
Caco-2 Permeability I |
Caco2-
|
Caco-2 Permeability II |
-0,1297
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor I |
Non-inhibitor
|
P-glycoprotein Inhibitor II |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
AMES Toxicity |
AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity I |
High FHMT
|
Fish Toxicity II |
1,4604
|
Tetrahymena Pyriformis Toxicity I |
High TPT
|
Tetrahymena Pyriformis Toxicity II |
0,5226
|
Tetrahymena Pyriformis Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity |
2,5708
|
Carcinogenicity (Three-class) |
Non-required
|